During 2019, there were a total of 1,837 active pipeline immuno-oncological agents in development in the United States. Of these, 507 were cell therapy drugs and 464 were other immunomodulator agents. This statistic shows the active immuno-oncological agents in drug development pipeline in the U.S. in 2019, by therapy type.
Active immuno-oncological agents in development in the U.S. in 2019, by therapy type
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Nature. (September 27, 2019). Active immuno-oncological agents in development in the U.S. in 2019, by therapy type [Graph]. In Statista. Retrieved November 03, 2024, from https://www.statista.com/statistics/1093807/active-io-agents-in-drug-development-pipeline-by-therapy-us/
Nature. "Active immuno-oncological agents in development in the U.S. in 2019, by therapy type." Chart. September 27, 2019. Statista. Accessed November 03, 2024. https://www.statista.com/statistics/1093807/active-io-agents-in-drug-development-pipeline-by-therapy-us/
Nature. (2019). Active immuno-oncological agents in development in the U.S. in 2019, by therapy type. Statista. Statista Inc.. Accessed: November 03, 2024. https://www.statista.com/statistics/1093807/active-io-agents-in-drug-development-pipeline-by-therapy-us/
Nature. "Active Immuno-oncological Agents in Development in The U.S. in 2019, by Therapy Type." Statista, Statista Inc., 27 Sep 2019, https://www.statista.com/statistics/1093807/active-io-agents-in-drug-development-pipeline-by-therapy-us/
Nature, Active immuno-oncological agents in development in the U.S. in 2019, by therapy type Statista, https://www.statista.com/statistics/1093807/active-io-agents-in-drug-development-pipeline-by-therapy-us/ (last visited November 03, 2024)
Active immuno-oncological agents in development in the U.S. in 2019, by therapy type [Graph], Nature, September 27, 2019. [Online]. Available: https://www.statista.com/statistics/1093807/active-io-agents-in-drug-development-pipeline-by-therapy-us/
